Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial.

Sangkanjanavanich, Sasipa; Pradubpongsa, Panitan; Mitthamsiri, Wat; Sangasapaviliya, Atik; Boonpiyathad, Tadech

Sangkanjanavanich, Sasipa; Pradubpongsa, Panitan; Mitthamsiri, Wat; Sangasapaviliya, Atik; Boonpiyathad, Tadech.

Afiliación

Sangkanjanavanich S; Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pradubpongsa P; Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand.
Mitthamsiri W; Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand.
Sangasapaviliya A; Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand.
Boonpiyathad T; Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand. Electronic address: tadechb@pmk.ac.th.

Ann Allergy Asthma Immunol ; 129(6): 790-792, 2022 12.

Article en En | MEDLINE | ID: mdl-36089255

Asunto(s)

Asma; Probióticos; Humanos; Bifidobacterium longum subspecies infantis; Bifidobacterium; Probióticos/uso terapéutico; Asma/terapia; Método Doble Ciego

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Probióticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google